Novo Nordisk cuts 215 jobs at New Jersey headquarters

Novo Nordisk will cut 215 jobs at its US headquarters in New Jersey this February as part of a sales organization redesign.

Layoffs ยท Source: NJBIZ

What happened

Novo Nordisk filed a state workforce notice to cut 215 jobs at its Plainsboro, New Jersey headquarters. These reductions will take place between February 17 and February 19, 2027. The state summary notice identifies the affected workforce and dates. However, the company did not specify which exact job titles or departments will be eliminated.

This upcoming round of cuts is separate from an earlier notice filed in September 2026. That previous notice covered 108 job cuts at the exact same Plainsboro location. Those earlier reductions are scheduled to take effect on December 31, 2026. This means the facility will see two distinct rounds of job losses within a few months.

A company spokesperson stated that Novo Nordisk is redesigning its United States sales organization. The drugmaker aims to create a leaner commercial model to adapt to changing market conditions and patient needs. The Plainsboro headquarters currently houses corporate operations, medical affairs, and clinical-trial management functions. The company stated it is providing support to impacted colleagues during this transition.

By the numbers

Why it matters

Job seekers looking at the pharmaceutical sector need to understand that even companies producing high-demand products are restructuring. Novo Nordisk makes popular medications like Ozempic and Wegovy, yet it is still reducing its corporate and commercial headcount. This means candidates applying for sales or corporate roles at major drugmakers may face fewer open positions. Companies are prioritizing lean operations over rapid expansion. Job seekers should prepare for a tighter hiring market in commercial pharmaceutical roles.

The lack of specific job titles in the state notice creates uncertainty for the local New Jersey job market. Hundreds of professionals from commercial operations, medical affairs, and clinical-trial management will soon enter the candidate pool. Local employers may see a sudden influx of highly qualified pharmaceutical talent looking for new roles early next year. This increased competition means active job seekers need to move quickly. Hiring managers will have more candidates to choose from in the coming months.

Who this hits

Corporate and commercial staff

Workers at the Plainsboro headquarters face direct impact from these reductions. The facility houses commercial operations and medical affairs, meaning professionals in these areas may need to find new roles.

Pharmaceutical job seekers

Candidates looking for sales or corporate roles in the New Jersey area will face increased competition. With over three hundred workers leaving Novo Nordisk between December and February, the local talent pool will be crowded.

Immigrant workers

Employees on H-1B or OPT visas at the Plainsboro site face strict timelines if their roles are eliminated. They will need to secure new employment quickly to maintain their legal status in the United States.

What to do this week

See who's hiring right now on GiraffyReach

My take

Companies will restructure their teams even when their core products are highly successful. I always tell job seekers to keep their skills sharp and their networks active, regardless of how stable their current employer seems. If you are affected by these cuts, start your search now before the February effective date.

Sources

More job market news